Get the Stockscreener App
170.89
0.80%
-1.37
After Hours:
170.89
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $170.89, with a volume of 420.94K.
It is down -0.80% in the last 24 hours and up +22.65% over the past month.
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$172.26
Open:
$173.12
24h Volume:
420.94K
Relative Volume:
0.62
Market Cap:
$9.12B
Revenue:
$2.04B
Net Income/Loss:
$78.60M
P/E Ratio:
80.23
EPS:
2.13
Net Cash Flow:
$149.60M
1W Performance:
+3.60%
1M Performance:
+22.65%
6M Performance:
+34.56%
1Y Performance:
+79.36%
1-Day Range:
$170.55
$175.00
1-Week Range:
$163.80
$178.28
52-Week Range:
$91.60
$178.28
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
170.89 | 9.12B | 2.04B | 78.60M | 149.60M | 2.13 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Responds to ‘Speculative Articles’ on Sound United - Strata-gee.com
Hedge Fund RTW Probed by SEC Over Role in Masimo Proxy Fight - Yahoo Finance
FY2024 Earnings Estimate for Masimo Issued By Zacks Research - MarketBeat
Algert Global LLC Has $2.55 Million Stake in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo to Present at Piper Sandler's 36th Annual Healthcare Conference | MASI Stock News - StockTitan
Masimo Co. (NASDAQ:MASI) Shares Acquired by Westfield Capital Management Co. LP - MarketBeat
Kiani-Friendly Firm Fires Back at Masimo Voting Claims (1) - Bloomberg Law
Masimo stock soars to 52-week high, hits $173.91 By Investing.com - Investing.com Canada
Masimo stock soars to 52-week high, hits $173.91 - Investing.com India
MASI (Masimo) Momentum Rank : 10 (As of Nov. 22, 2024) - GuruFocus.com
Breaking Down Masimo: 5 Analysts Share Their Views - Benzinga
Masimo's (MASI) Buy Rating Reaffirmed at Stifel Nicolaus - MarketBeat
Brown Capital Management LLC Sells 22,407 Shares of Masimo Co. (NASDAQ:MASI) - MarketBeat
3,584 Shares in Masimo Co. (NASDAQ:MASI) Bought by Oppenheimer Asset Management Inc. - MarketBeat
Masimo Corp announces strategic shift, EVP departs By Investing.com - Investing.com Australia
Masimo Signs Michelle Brennan to New Employment Agreement - Orange County Business Journal
Masimo appoints interim CEO to a six-month term - Investing.com
Principal Financial Group Inc. Lowers Stake in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo Co. (NASDAQ:MASI) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
GSA Capital Partners LLP Sells 3,978 Shares of Masimo Co. (NASDAQ:MASI) - MarketBeat
ING Groep NV Increases Stock Position in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo Can't Tie Alleged IP Theft To Apple Profits, Expert Says - Law360
Beat the Market Like Zacks: Sprouts Farmers Market, Kroger, Masimo in Focus - Yahoo Finance
Retrial Begins for Masimo, Apple - Orange County Business Journal
MASIMO CORP : Results of Operations and Financial Condition (form 8-K) - Marketscreener.com
Apple Didn't Hire Cercacor CTO To Steal Watch IP, Ex-VP Says - Law360
Masimo Spinoff's Ex-CTO Denies Giving Apple Trade Secrets - Law360
Masimo Corporation (NASDAQ:MASI) Q3 2024 Earnings Call Transcript - Insider Monkey
Malaga Cove Capital LLC Buys New Stake in Masimo Co. (NASDAQ:MASI) - MarketBeat
MASI (Masimo) Debt-to-EBITDA : 3.39 (As of Sep. 2024) - GuruFocus.com
Masimo Expert Cites LED And Foam As Evidence Apple Stole IP - Law360
Masimo shares upgraded to Outperform by Raymond James on potential - Investing.com Nigeria
Masimo shares price target increased on strong Q3 results - Investing.com
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth - Yahoo Finance
Masimo stock soars to 52-week high, hits $173.9 amid robust growth By Investing.com - Investing.com South Africa
Masimo stock soars to 52-week high, hits $173.9 amid robust growth - Investing.com Canada
Masimo (NASDAQ:MASI) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Masimo (FRA:3M4) Total Inventories : €477 Mil (As of Jun. 2024) - GuruFocus.com
Masimo shares price target increased on strong Q3 results By Investing.com - Investing.com UK
Masimo's (MASI) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Masimo, amid leadership transition, targets cost reductions - Yahoo Finance
Masimo v Apple retrial begins over oxygen readings on watches - Daily Journal
Masimo Corp (MASI) Q3 2024 Earnings Call Highlights: Strong Heal - GuruFocus.com
Masimo Corp (MASI) Q3 2024 Earnings Call Highlights: Strong Healthcare Growth Amid ... - Yahoo Finance
Masimo Corp. Reports Strong Q3 2024 Performance - TipRanks
Apple Stole Masimo Sensor IP, Calif. Judge Told At Trial's Start - Law360
Apple, Masimo Return for Narrowed Smart Watch Trade Secret Trial - Bloomberg Law
Masimo (MASI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Masimo (MASI) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Masimo Corp (MASI) Q3 2024 Earnings: EPS of $0.18, Revenue Hits $504.6 Million, Surpassing Estimates - GuruFocus.com
Masimo: Q3 Earnings Snapshot - San Antonio Express-News
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):